Servais, S., & Baron, F. (2017). Chapitre: Maladie du greffon contre l'hôte chronique. In Mohty Mohamad & Brissot Eolia, Allogreffe de cellules souches hématopoïétiques - Manuel de pratique. LGM Sciences.  Editorial reviewed |
  | LEJEUNE, M., Menard, B., Servais, S., ANDRIANNE, C., Capelle, L., De Maistre, S., Fabaron, C., Cornier, M. F., Goutagny, M.-P., Pereira, M., Tardy, C., Turquet, E., Benakli, M., BAUDOUX, E., Evard, S., Faucher, C., Herrero, G., RESILIAM, Magro, L., & Geurten, C. (2025). Don de cellules souches hématopoïétiques à partir d’un donneur mineur : cadre réglementaire, information, évaluation de l’aptitude au don et parcours (SFGM-TC). Bulletin du Cancer, 112, 78-S86. doi:10.1016/j.bulcan.2024.04.002 Peer Reviewed verified by ORBi |
  | Lombardo, G., LECHANTEUR, C., BRIQUET, A., Seidel, L., Willems, E., Servais, S., BAUDOUX, E., Kerre, T., Zachee, P., HERMAN, J., JANSSEN, A., MULLER, J., Baron, F., & Beguin, Y. (03 December 2024). Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature review. Stem Cell Research and Therapy, 15 (1), 461. doi:10.1186/s13287-024-04064-w Peer Reviewed verified by ORBi |
 | Lambert, N., Forte, F., El Moussaoui, M., Monseur, J., Raus, N., Polushin, A., Michonneau, D., Shultz, C., Hogan, W. J., Balaguer-Roselló, A., Gil-Perotìn, S., Brijs, J., Chauvet, P., Gavriilaki, M., Carre, M., Dulamea, A. O., Chalandon, Y., Salmenniemi, U., Duminuco, A., ... CNS-GvHD Study Group. (2024). Central nervous system manifestations in acute and chronic graft-versus-host disease. Brain: a Journal of Neurology. doi:10.1093/brain/awae340 Peer Reviewed verified by ORBi |
 | Villar, S., Chevret, S., Poire, X., Joris, M., Chevallier, P., Bourhis, J.-H., Forcade, E., Chantepie, S., Beauvais, D., Raus, N., Bay, J.-O., Loschi, M., Devillier, R., Duléry, R., Ceballos, P., Rubio, M. T., Servais, S., Nguyen, S., & Robin, M. (July 2024). Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Bone Marrow Transplantation, 59 (7), 965 - 973. doi:10.1038/s41409-024-02268-5 Peer Reviewed verified by ORBi |
 | Bayoudh, F., Giot, J.-B., Descy, J., Fontaine, C., Hayette, M.-P., Baron, F., WILLEMS, E., Beguin, Y., FRIPPIAT, F., & Servais, S. (March 2024). Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 72 (1), 103422. doi:10.1016/j.retram.2023.103422 Peer Reviewed verified by ORBi Dataset: 10.1016/j.retram.2023.103422 |
 | BARZIN, A., MAQUET, C., Devey, A., Gothot, A., DUBOIS, B., Beguin, Y., Caers, J., & Servais, S. (2024). Y a-t-il une place pour les transfusions de granulocytes en 2023 ? Revue Médicale de Liège, 79, 80-87. Editorial Reviewed verified by ORBi |
 | Lamberink, H., Huygens, S., Aerts, R., Lagrou, K., van Leeuwen-Segarceanu, E., Lodewyck, T., Nieuwenhuizen, L., Corsten, M. F., Moors, I., Servais, S., De Greef, J., Hites, M., Demandt, A., Schauwvlieghe, A., Maertens, J., & Rijnders, B. (2024). Superiority trials in invasive aspergillosis: a harsh reality check with the IA-DUET (HOVON502) trial. Clinical Infectious Diseases, ciae501. doi:10.1093/cid/ciae501 Peer Reviewed verified by ORBi |
 | Voisot, A., Triffaux, F., Roland, I., Meex, C., Detrembleur, N., Baron, F., WILLEMS, E., WALTREGNY, D., Beguin, Y., & Servais, S. (22 September 2023). Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 71 (1), 103366. doi:10.1016/j.retram.2022.103366 Peer Reviewed verified by ORBi |
 | Ritacco, C., Köse, M. C., Courtois, J., Canti, L., Beguin, C., DUBOIS, S., Vandenhove, B., Servais, S., Caers, J., Beguin, Y., Ehx, G.* , & Baron, F.*. (17 March 2023). Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience, 26 (3), 106085. doi:10.1016/j.isci.2023.106085 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Servais, S., Baron, F., LECHANTEUR, C., Seidel, L., BAUDOUX, E., BRIQUET, A., Selleslag, D., Maertens, J., Poire, X., Schroyens, W., Graux, C., De Becker, A., Zachee, P., Ory, A., Herman, J., Kerre, T., & Beguin, Y. (2023). Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1106464 Peer Reviewed verified by ORBi |
 | Troisfontaine, F., Denis, C., Servais, S., Lousberg, L., & Jerusalem, G. (December 2022). Les CAR-T cells dans le traitement des tumeurs solides : où en sommes-nous ? Revue Médicale de Liège, 77 (12), 706 - 709. Editorial Reviewed verified by ORBi |
 | Srour, M., Fayard, A., Giannotti, F., Giltat, A., Guenounou, S., Roy, J., SCHMITT, J., Servais, S., Alsuliman, T., Agha, I. Y., & Guillerm, G. (2022). Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) 2021. Bulletin du Cancer. doi:10.1016/j.bulcan.2022.09.003 Peer Reviewed verified by ORBi |
 | De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266 Peer Reviewed verified by ORBi |
 | SERVAIS, S., BEGUIN, Y., & BARON, F. (27 May 2022). Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia. Stem Cells Translational Medicine, 11 (5), 461-477. doi:10.1093/stcltm/szac015 Peer Reviewed verified by ORBi |
 | BARZIN, A., Geurten, C., WILLEMS, E., Baron, F., Beguin, Y., & Servais, S. (May 2022). Maladie du greffon contre l’hôte aiguë et chronique après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 77 (5-6), 345 - 353. Editorial Reviewed verified by ORBi |
 | Canti, L., Ariën, K. K., Desombere, I., Humblet-Baron, S., Pannus, P., Heyndrickx, L., HENRY, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., SEIDEL, L., Michiels, J., Willems, B., Goossens, M. E., Beguin, Y., Marchant, A., & Baron, F. (11 April 2022). Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients. Cancer Cell, 40 (4), 335-337. doi:10.1016/j.ccell.2022.02.005 Peer Reviewed verified by ORBi |
 | GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211. Editorial Reviewed verified by ORBi |
 | Courtois, J., Ritacco, C., DUBOIS, S., Canti, L., Vandenhove, B., SEIDEL, L., Daulne, C., CAERS, J., SERVAIS, S., Beguin, Y., Ehx, G., & BARON, F. (2021). Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplantation, 56, 2672-2681. doi:10.1038/s41409-021-01363-1 Peer Reviewed verified by ORBi |
 | Narinx, J., SERVAIS, S., BARON, F., BEGUIN, Y., & WILLEMS, E. (2021). Allogreffes de cellules souches hématopoïétiques : principes généraux et progrès récents. Revue Médicale de Liège, 76, 464-469. Peer reviewed |
 | MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481. Peer reviewed |
 | Rubio, M., Varlet, P., Allain, V., Ballot, C., Cuffel, A., Deschamps, M., Ferrand, C., FOGUENNE, J., Forcade, E., Huynh, A., Guihot, A., Latouche, J.-B., Lemarie, C., Martinroche, G., Morin, F., Nguyen, S., SCHMIT, K., SERVAIS, S., Simonetta, F., ... Zucman, S. (2021). Suivi immunologique des patients traités par cellules CAR-T pour hémopathie maligne: recommandations du groupe CARTi et de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Bulletin du Cancer, 108, 53-S64. doi:10.1016/j.bulcan.2021.04.008 Peer Reviewed verified by ORBi |
 | Ritacco, C.* , Ehx, G.* , GREGOIRE, C., Daulne, C., WILLEMS, E., SERVAIS, S., BEGUIN, Y., & Baron, F. (2021). High proportion of terminally-differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 56, 1828-1841. doi:10.1038/s41409-021-01221-0 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Canti, L.* , Humblet-Baron, S.* , Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K. K., Beguin, Y., Goossens, M. E., Marchant, A., & Baron, F. (2021). Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of Hematology and Oncology, 14 (1), 174. doi:10.1186/s13045-021-01190-3 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Catalano, C., SERVAIS, S., BONVOISIN, C., Couturier, B., Hildebrand, M., Etienne, I., MEURIS, C., Goffard, J.-C., Wissing, M., Goldman, M., & Le Moine, A. (2021). Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients. Transplantation, 105, 282. doi:10.1097/TP.0000000000003942 Peer Reviewed verified by ORBi |
 | Ehx, G.* , Ritacco, C.* , HANNON, M., DUBOIS, S., Delens, L., WILLEMS, E., SERVAIS, S., Drion, P., BEGUIN, Y., & Baron, F. (2021). Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. American Journal of Transplantation, 21, 2662-2674. doi:10.1111/ajt.16505 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Vandenhove, B., Canti, L., Schoemans, H., Beguin, Y., Baron, F., Graux, C., Kerre, T., & SERVAIS, S. (21 October 2020). How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Frontiers in Immunology, 11, 583564. doi:10.3389/fimmu.2020.583564 Peer Reviewed verified by ORBi |
 | Vandenhove, B.* , Canti, L.* , Schoemans, H., BEGUIN, Y., BARON, F., WILLEMS, E., Graux, C., Kerre, T.* , & SERVAIS, S.*. (2020). Acute graft-versus-host disease: diagnosis, pathophysiology and prevention. Belgian Journal of Hematology, 11 (4), 159-173. Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Delens, L., Ehx, G., SOMJA, J., Vrancken, L., Belle, L., SEIDEL, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & Servais, S. (2019). In Vitro Th17-Polarized Human CD4(+) T Cells Exacerbate Xenogeneic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation, 25, 204-215. doi:10.1016/j.bbmt.2018.10.007 Peer Reviewed verified by ORBi |
 | Grégoire, C., Ritacco, C., Hannon, M., SEIDEL, L., Delens, L., Belle, L., DUBOIS, S., Veriter, S., LECHANTEUR, C., BRIQUET, A., Servais, S., Ehx, G., Beguin, Y., & Baron, F. (2019). Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Frontiers in Immunology, 10, 619. doi:10.3389/fimmu.2019.00619 Peer Reviewed verified by ORBi |
 | Dendoncker, C., Brouillat, C., Daufrene, L., Deledicque, V., Cheikh, J. E., Gibault-Joffe, C., Guilbert, Y., Guidi, V., Hadrot, L., Haran, I., Kermeur, G., Kernoa, K., L'Hostette, A., Mercier, L., Mouneydier, K., SERVAIS, S., WITHOFS, S., Yakoub-Agha, I., & Farrugia, C. (2019). Oral feeding of patient hospitalized for allogeneic stem cells transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) [Alimentation orale du patient hospitalisé pour une allogreffe de cellules souches hématopoïétiques : recommandations de la Société Francophone de Greffe de Mœlle et de Thérapie Cellulaire (SFGM-TC)]. Bulletin du Cancer. doi:10.1016/j.bulcan.2019.07.010 Peer Reviewed verified by ORBi |
 | Vrancken, L., Muller, J., Lejeune, M., Grégoire, C., Delens, L., Jaspers, A., Servais, S., DE PRIJCK, B., Baron, F., Caers, J., & Beguin, Y. (2018). Nouveautes dans la prise en charge du myelome. Revue Médicale Suisse, 14 (615), 1438-1442. Peer Reviewed verified by ORBi |
 | Servais, S., Baron, F., LECHANTEUR, C., SEIDEL, L., Selleslag, D., Maertens, J., BAUDOUX, E., Zachee, P., Van Gelder, M., Noens, L., Kerre, T., Lewalle, P., Schroyens, W., ORY, A., & Beguin, Y. (2018). Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study. Oncotarget, 9 (29), 20590-20604. doi:10.18632/oncotarget.25020 Peer Reviewed verified by ORBi |
 | Pirotte, M.* , Forte, F.* , Lutteri, L., WILLEMS, E., DURAN, U., Belle, L., Baron, F., BEGUIN, Y., Maquet, P., BODART, O.* , & Servais, S.*. (2018). Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Journal of Neuroimmunology, 323, 115-118. doi:10.1016/j.jneuroim.2018.08.003 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | SERVAIS, S., Hannon, M., Peffault de Latour, R., Socie, G., & BEGUIN, Y. (2017). Reconstitution of adaptive immunity after umbilical cord blood transplantation and clinical implication regarding risk of infections. Stem Cell Investigation, 4, 40. Peer Reviewed verified by ORBi |
 | Vrancken, L., Delens, L., BEGUIN, Y., BARON, F., & SERVAIS, S. (2017). Focus sur les lymphocytes T dans la maladie du greffon contre l'hôte après allogreffe de cellules soucges hématopoïétiques: implications pour de nouvelles stratégies de prévention. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 11, 23-31. Peer reviewed |
 | Bay, Dendoncker, C., Angeli, M., BIOT, T., Chikhi, M., Combal, C., Jouannic, L., Kermeur, G., Lopvet, L., Marchand, T., Schmitt, S., SERVAIS, S., Yakoub-Agha, I., & Seguy, D. (November 2016). Nutritional management for patients hospitalized during allogeneic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Bulletin du Cancer, 103 (11S), 201-S206. doi:10.1016/j.bulcan.2016.09.014 Peer Reviewed verified by ORBi |
 | Glauzy, S., Peffault de Latour, R., André-Schmutz, I., Lachuer, J., SERVAIS, S., SOCIE, G., CLAVE, E., & TOUBERT, A. (September 2016). Alterations of circulating lymphoid committed progenitor cellular metabolism after allogeneic stem cell transplantation in humans. Experimental Hematology, 44 (9), 811-816. doi:10.1016/j.exphem.2016.05.008 Peer reviewed |
 | SERVAIS, S., BEGUIN, Y., Delens, L., Ehx, G., Fransolet, G., Hannon, M., WILLEMS, E., Humblet-Baron, S., Belle, L., & Baron, F. (11 May 2016). Novel approaches for preventing acute graftversus- host disease after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Investigational Drugs, 9, 957-972. doi:10.1080/13543784.2016.1182498 Peer Reviewed verified by ORBi |
 | SERVAIS, S., DUMONTIER, N., BIARD, L., SCHNEPF, N., RESCHE-RIGON, M., PEFFAULT DE LATOUR, R., SCIEUX, C., ROBIN, M., MEUNIER, M., XHAARD, A., SICRE DE FONTBRUNE, F., LE GOFF, J., SOCIE, G., SIMON, F., & MAZERON, M.-C. (March 2016). Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status. Clinical Microbiology and Infection, 22 (3), 289e1-7. doi:10.1016/j.cmi.2015.11.006 Peer Reviewed verified by ORBi |
 | SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235. Peer Reviewed verified by ORBi |
 | JASPERS, A., Baron, F., SERVAIS, S., LEJEUNE, M., WILLEMS, E., SEIDEL, L., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (September 2015). Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival. American Journal of Hematology, 90 (9), 197-199. doi:10.1002/ajh.24100 Peer Reviewed verified by ORBi |
 | HANNON, M., BEGUIN, Y., Ehx, G., SERVAIS, S., SEIDEL, L., Graux, C., Maertens, J., Kerre, T., Daulne, C., de Bock, M., Fillet, M., ORY, A., WILLEMS, E., GOTHOT, A., Humblet-Baron, S., & BARON, F. (15 July 2015). Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning. Clinical Cancer Research, 21 (14), 3131-9. doi:10.1158/1078-0432.CCR-14-3374 Peer Reviewed verified by ORBi |
 | SERVAIS, S., Baron, F., & BEGUIN, Y. (2015). Impact of graft source and composition on outcomes after allogeneic stem cell transplantation. Belgian Journal of Hematology, 6 (4), 162-168. Peer Reviewed verified by ORBi |
 | Servais, S., BAUDOUX, E., Brichard, B., Bron, D., Debruyn, C., De Bruyère, M., De Hemptinne, D., Deneys, V., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Van Cauwenberge, J., Cornu, G., Delforge, A., & Beguin, Y. (January 2015). Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica, 100 (1), 32-34. doi:10.3324/haematol.2014.115394 Peer Reviewed verified by ORBi |
 | SERVAIS, S., Menten-Dedoyart, C., Beguin, Y., SEIDEL, L., Gothot, A., Daulne, C., WILLEMS, E., Delens, L., Humblet-Baron, S., Hannon, M., & Baron, F. (2015). Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation. PLoS ONE, 10 (6), 0130026. doi:10.1371/journal.pone.0130026 Peer Reviewed verified by ORBi |
 | SERVAIS, S., Lengline, E., Porcher, R., Carmagnat, M., Peffault de Latour, R., Robin, M., Sicre de Fontebrune, F., Clave, E., Maki, G., Granier, C., Xhaard, A., Dhedin, N., Molina, J.-M., Toubert, A., Moins-Teisserenc, H., & Socie, G. (April 2014). Long term Immune Reconstitution and infection burden after Mismatched Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 20 (4), 507-517. doi:10.1016/j.bbmt.2014.01.001 Peer Reviewed verified by ORBi |
 | Glauzy, S., André-Schmutz, I., Larghero, J., Ezine, S., Peffault de Latour, R., Moins-Teisserenc, H., SERVAIS, S., Robin, M., Socie, G., Clave, E., & Toubert, A. (12 March 2014). CXCR4-related increase of circulating human lymphoid progenitors after allogeneic hematopoietic stem cell transplantation. PLoS ONE, 9 (3), 91492. doi:10.1371/journal.pone.0091492 Peer Reviewed verified by ORBi |
 | SERVAIS, S., Porcher, R., Xhaard, A., Robin, M., Masson, E., Larghero, J., Ribaud, P., Dhedin, N., Abbes, S., Sicre, F., Socie, G., & Peffault de Latour, R. (March 2014). Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors. Haematologica, 99 (3), 519-526. doi:10.3324/haematol.2013.089979 Peer Reviewed verified by ORBi |
 | de Masson, A., Beylot-Barry, M., Bouaziz, J.-D., Peffault de Latour, R., Aubin, F., Garciaz, S., d’Incan, M., Dereure, O., Dalle, S., Dompmartin, A., Suarez, F., Battistella, M., Vignon-Pennamen, M.-D., Rivet, J., Adamski, H., Brice, P., Sylvie, F., Lissandre, S., Turlure, P., ... Bagot, M. (March 2014). Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. Haematologica, 99 (3), 527-534. doi:10.3324/haematol.2013.098145 Peer Reviewed verified by ORBi |
 | Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9 Peer Reviewed verified by ORBi |
 | BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552 Peer Reviewed verified by ORBi |
 | SERVAIS, S., Beguin, Y., & Baron, F. (2013). Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Emerging Drugs, 18 (2), 173-192. doi:10.1517/14728214.2013.798642 Peer Reviewed verified by ORBi |
 | SERVAIS, S., WILLEMS, E., Beguin, Y., & Baron, F. (2013). Allogreffe de cellules souches hématopoïétiques chez le patient âgé : jusqu'à quel âge ? Revue Médicale de Liège, 68 (1), 38-43. Peer reviewed |
 | FRUSCH, N., SERVAIS, S., DE PRIJCK, B., Corhay, J.-L., Beguin, Y., Louis, R., & DUYSINX, B. (2012). Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis. Acta Clinica Belgica, 67-68. doi:10.2143/ACB.67.5.2062693 Peer Reviewed verified by ORBi |
 | VERTENOEIL, G., SERVAIS, S., & Beguin, Y. (2012). Comment j'explore... une fièvre d'origine indéterminée chez le patient adulte ? Revue Médicale de Liège, 67 (7-8), 391-397. Peer reviewed |
 | Baron, F., & SERVAIS, S. (2012). Rituximab et maladie du greffon contre l'hôte chronique. Horizons Hemato, 2 (2), 78-81. Peer reviewed |
 | Malaise, O., FRUSCH, N., BECK, E., Servais, S., BETEA, D., CAERS, J., DE PRIJCK, B., & BEGUIN, Y. (2012). Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphoma. Leukemia and Lymphoma, 53 (12), 2515-16. Peer Reviewed verified by ORBi |
 | SERVAIS, S., & Baron, F. (2012). Allogreffe de cellules souches hématopoïétiques après conditionnements réduits ("minigreffes") comme traitement de certaines pathologies hématologiques malignes. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 6, 6-12. Peer reviewed |
 | SERVAIS, S., Baron, F., & Beguin, Y. (2011). Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning. Transfusion and Apheresis Science, 44, 205-210. doi:10.1016/j.transci.2011.01.019 Peer Reviewed verified by ORBi |
 | Servais, S., Beguin, Y., & Baron, F. (2011). Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT). Belgian Journal of Hematology, 2, 3-9. Peer Reviewed verified by ORBi |
 | Servais, S., Willems, E., Beguin, Y., & Baron, F. (2010). Maladie du greffon contre l'hôte chronique : une prise en charge multidisciplinaire. Revue Médicale de Liège, 65, 81-87. Peer reviewed |
 | Servais, S., Caers, J., Warling, O., Frusch, N., Baron, F., De Prijck, B., & Beguin, Y. (2010). Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. British Journal of Haematology, 150 (3), 379-381. doi:10.1111/j.1365-2141.2010.08202.x Peer Reviewed verified by ORBi |
 | SERVAIS, S., SCHOLTES, F., Roemers, S., & Martin, D. (2009). La thrombose veineuse cérébrale (TVC). Revue Médicale de Liège, 64 (1), 25-31. Peer reviewed |
 | Debabeche, C., Muselle, A., Servais, S., Farcy, L., Barbier, V., Laloyaux, C., Mikolajczak, G., & Desseilles, M. (2009). Trouble obsessionnel-compulsif (TOC). Revue Médicale Suisse, 5 (214), 1659-62. Peer Reviewed verified by ORBi |
 | Servais, S., Ansseau, M., Mikolajczak, G., & Desseilles, M. (2008). L'électroconvulsivothérapie en 2008. Revue Médicale de Liège, 63, 404-410. Peer reviewed |
 | Ritacco, C., Ehx, G., Canti, L., DUBOIS, S., Vandenhove, B., SERVAIS, S., Beguin, Y., & Baron, F. (01 March 2020). Ptcy Prevents Xenogeneic Gvhd without Abrogating Gvl Effects. Biology of Blood and Marrow Transplantation, 26 (3), 168. doi:10.1016/j.bbmt.2019.12.028 Peer Reviewed verified by ORBi |
 | JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948. Peer Reviewed verified by ORBi |
 | Servais, S., Lenglinne, E., Porcher, R., Carmagnat, M., Peffault de Latour, R., Maki, G., Clémence, G., Robin, M., Clave, E., Xhaard, A., Dhedin, N., Toubert, A., Moins-Teisserenc, H., & Socie, G. (08 April 2013). Immune Reconstitution After Alternative Hematopoietic Stem Cell Transplantation: Comparison of Unrelated Cord Blood and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation, 48 (S2), 132. Peer Reviewed verified by ORBi |
 | Servais, S., Porcher, R., Robin, M., Xhaard, A., Masson, E., Larghero, J., Ribaud, P., Dhedin, N., Abbes, S., Socie, G., & Peffault de Latour, R. (November 2012). Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood Stem Cell Transplantation From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies. Blood, 120, 2000. Peer Reviewed verified by ORBi |
 | SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (February 2012). Longitudinal Monitoring of Immune Reconstitution after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): Impact of T-Cell Depletion of the Graft. Biology of Blood and Marrow Transplantation, 18 (2), 274-S275. doi:10.1016/j.bbmt.2011.12.193 Peer Reviewed verified by ORBi |
 | Belle, L., Baron, F., Bruck, F., Hannon, M., SERVAIS, S., Beguin, Y., & BRIQUET, A. (2011). Despite inhibitory effects on normal hematopoiesis in vitro, Imatinib and Nilotinib do not prevent engraftment of human CD34+ HSCs in immunodeficient NSG mice. Belgian Journal of Hematology. Peer Reviewed verified by ORBi |
 | SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (2011). Longitudinal Monitoring of Immune Reconstitution After Allogeneic Peripheral Blood Stem Cell Transplantation (HSCT): Impact of T Cell Depletion of the Graft. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 31. |
 | Mina, M., Horrion Jil, SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., MALAISE, M., & MALAISE, O. (September 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Belgian Congress of Rheumatology. Peer reviewed |
 | Mina, M., Horrion, J., SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., Malaise, M., & MALAISE, O. (March 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Bone Curriculum Symposium 2019. Peer reviewed |